Norio Horiike
Overview
    Explore the profile of Norio Horiike including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              114
            
            
              Citations
              1019
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, et al.
  
  
    Sci Rep
    . 2023 Jun;
          13(1):8992.
    
    PMID: 37268672
  
  
          The time point of the most precise predictor of hepatocellular carcinoma (HCC) development after viral eradication with direct-acting antiviral (DAA) therapy is unclear. In this study we developed a scoring...
      
2.
        
    
    Takahashi S, Kushibe T, Akezaki Y, Horiike N
  
  
    Acta Med Okayama
    . 2022 Sep;
          76(4):423-428.
    
    PMID: 36123157
  
  
          We compared the effects of an exercise intervention with that of exercise combined with nutrition therapy in patients with possible malnutrition and sarcopenia admitted to a recovery rehabilitation ward, and...
      
3.
        
    
    Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, et al.
  
  
    BMC Cancer
    . 2021 Jun;
          21(1):699.
    
    PMID: 34126947
  
  
          Background: An unexpected recurrence of hepatocellular carcinoma (HCC) sometimes occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals (DAAs). However, the characteristics of patients with HCC...
      
4.
        
    
    Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, et al.
  
  
    J Med Virol
    . 2020 May;
          92(12):3507-3515.
    
    PMID: 32374470
  
  
          Sex differences in the predictors for hepatocellular carcinoma (HCC) development after direct-acting antiviral (DAA) therapy was investigated. DAA therapy was given to 1438 (663 male, 775 female) patients. Sex differences...
      
5.
        
    
    Kashimoto Y, Onji M, Takeji S, Yamamoto S, Miyake T, Uehara T, et al.
  
  
    Euroasian J Hepatogastroenterol
    . 2020 Jan;
          9(1):52-54.
    
    PMID: 31988868
  
  
          Two female siblings aged 87 and 90 years were clinically diagnosed as pancreatic cancer by abdominal ultrasonography and abdominal contrast-enhanced CT. Pancreatic cancer of these patients was confirmed during the...
      
6.
        
    
    Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, et al.
  
  
    Hepatol Res
    . 2018 Oct;
          49(2):136-146.
    
    PMID: 30335208
  
  
          Aim: The predictors for the development of hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) treatment were investigated. Methods: A total of 1174 patients with chronic hepatitis C virus infection were...
      
7.
        
    
    Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, et al.
  
  
    J Med Virol
    . 2017 Feb;
          89(9):1567-1573.
    
    PMID: 28165154
  
  
          The tolerability and efficacy of sofosbuvir and ribavirin in patients infected with hepatitis C virus (HCV) genotype 2 were investigated under actual clinical conditions. A total of 208 patients with...
      
8.
        
    
    Watanabe T, Joko K, Seike H, Michitaka K, Horiike N, Kisaka Y, et al.
  
  
    Springerplus
    . 2016 May;
          5:518.
    
    PMID: 27186482
  
  
          Purpose: The tolerability and efficacy of simeprevir in combination with peginterferon and ribavirin in patients infected with hepatitis C virus (HCV) genotype 1 under actual clinical conditions were investigated. Methods:...
      
9.
        
    
    Koizumi Y, Hiraoka A, Michitaka K, Tazuya N, Ichiryu M, Nakahara H, et al.
  
  
    Clin J Gastroenterol
    . 2015 Jul;
          4(2):68-72.
    
    PMID: 26190708
  
  
          Hypoglycemia caused by insulin-like growth factor II is difficult to control. A 77-year-old woman was diagnosed with gastric cancer and multiple liver metastases in September 2006 and underwent chemotherapy; however,...
      
10.
        
    
    Michitaka K, Hiraoka A, Tokumoto Y, Ninomiya K, Ninomiya T, Horiike N, et al.
  
  
    Int J Hepatol
    . 2014 Oct;
          2014:358206.
    
    PMID: 25349743
  
  
          Background. Information regarding the progression of acute hepatitis B virus (HBV) infection to chronic infection in adults is scarce. Methods. Twenty-five adult patients with acute HBV infection (14 men and...